Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.4B | 1.4B | 1.4B | 1.5B |
Cost of revenue | 316M | 344M | 341M | 353M |
Gross profit | 1.1B | 1.1B | 1.1B | 1.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 351M | -634M | 504M | 467M |
Operating income | 410M | 342M | 286M | 333M |
Non operating interest income | ||||
Income | 2M | 6M | 9M | 12M |
Expense | 136M | 134M | 141M | 148M |
Other income expense | 40M | -62M | 4M | 4M |
Pretax income | 290M | 120M | 123M | 156M |
Tax provision | 71M | 67M | 66M | 78M |
Net income | 219M | 51M | 57M | 78M |
Basic EPS | 1.1 | 0.2 | 0.3 | 0.5 |
Diluted EPS | 1.1 | 0.2 | 0.3 | 0.5 |
Basic average shares | 189.8M | 192.1M | 192.2M | 192.1M |
Diluted average shares | 190.6M | 193.7M | 193.7M | 193.9M |
EBITDA | 697M | 543M | 574M | 618M |
Net income from continuing op. | 290M | 117M | 124M | 155M |
Minority interests | -26M | -19M | -6M | 0 |
Preferred stock dividends | — | — | — | — |